GlassScriptPhysician profile
Stephanie I Thompson
NPI 1760683197
$325.52
in general payments reported to CMS, 2019-2025
12 companies · $15.74 in 2025
The $15.74 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $38.37 · 2025: $15.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $64.70 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.44 | 2019 | |
| Boston Scientific Corporation | $34.04 | 2019 | |
| Scilex Pharmaceuticals INC. | $30.78 | 2019 | |
| Allergan, INC. | $23.65 | 2020 | |
| Daiichi Sankyo INC. | $20.82 | 2019 | |
| Eyepoint US, INC. | $18.00 | 2019 | |
| Nevro Corp. | $17.79 | 2019 | |
| Medline Industries LP | $15.74 | 2025 | |
| Medtronic USA, INC. | $14.72 | 2020 | |
| Collegium Pharmaceutical, INC. | $13.49 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.